Review reveals nanomaterial-driven enhancements in diagnostic sensitivity and speed for pathogens in clinical specimens, indicating significant potential for field-deployable disease control.
Nanomaterials, with their unique physicochemical properties, have emerged as important enabling components for improving the performance of point-of-care testing (POCT) technologies for pathogen detection. Many conventional POCT methods still face challenges in sensitivity, specificity, multiplexing capability, and quantitative accuracy, particularly when applied to low-abundance pathogens in complex clinical samples. This review first summarizes the functional roles of representative nanomaterials in pathogen POCT, including optical signal output, catalytic signal amplification, target enrichment, and interfacial regulation. We then discuss how these materials improve lateral flow assays, biosensors, microfluidic systems, and isothermal nucleic acid amplification platforms. Finally, we summarize three major nanomaterial-assisted recognition mechanisms, including pathogen surface recognition, ROS-mediated signal conversion, and nucleic acid recognition, and discuss their applications in respiratory, urinary, and fecal specimens. These advances are expected to support the development of more sensitive, integrated, and field-deployable diagnostic systems for infectious disease control.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: